Institute for Regenerative Medicine

About the Institute

The Texas A&M School of Medicine's Institute for Regenerative Medicine (IRM) at Baylor Scott & White Hospital was established in August 2008 as a joint venture between the Texas A&M School of Medicine, Scott & White Hospital (currently Baylor Scott & White Hospital), and the Temple Bioscience District. The IRM is also supported by investments from the Texas Emerging Technology Fund (TETF), which enabled the recruitment of leading investigators and innovative research programs in the field of regenerative medicine and cell therapy.

The goal of the IRM is to bridge the gap between basic science and clinical translation in the field of regenerative medicine and experimental cell therapeutics. Through active collaboration between basic scientists and clinicians in Central Texas, the IRM hopes to tackle the ambitious task of discovering novel therapies for intractable diseases to relieve human suffering.

The IRM is directed by Dr. Darwin Prockop, an internationally recognized investigator and member of the Institute of Medicine (IOM) and the National Academy of Sciences (NAS).

Prockop is a pioneer in the areas of human bone marrow-derived stem cells and their biology and clinical applications. Prior to joining The Texas A&M University System, he was director of the Center for Gene Therapy at the Tulane University Health Sciences Center in New Orleans.

"We have the opportunity to really make this work with the great doctors from Scott & White and scientists from the School of Medicine to help oversee it all. This is an ambitious program, but the potential payoff is just fantastic."
-Darwin Prockop